The G-2 Reports’ Laboratory Stock Index’s growth slowed a bit as the summer wrapped up. After a few months of five-week double-digit growth, the index was up 3 percent over the past five weeks for the week ended Sept. 18, 2009. However, the 13 publicly traded lab stocks tracked by the index are up 18 percent over the past 13 weeks, and 42 percent so far for full-year 2009, making for a strong end-of-the-summer finish. The Nasdaq and S&P 500 also continue to exhibit impressive strength. For 2009, the Nasdaq is up over 30 percent, while the S&P 500 is up almost 15 percent so far this year. Note that Monogram Biosciences (South San Francisco, Calif.) is no longer included in this monthly analysis, given its acquisition by Burlington, N.C.-based LabCorp.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

October 2009 - Table of Contents

LIR October 2009 (full PDF issue)

G-2 Reports’ Web-Based Connectivity Survey Finds 59% of Labs Connected to Physician EMR; Many Report Expected ROI in Less than 5 Years

Industry Exhales: $750 Million Tax Levy Dropped From Senate Finance Bill

Sonic Healthcare’s 2009 Revenues Up 27% to $2.5 Billion as Acquisition War Chest Grows to $644 Million

Genoptix, Myriad Genetics Continue to Lead in G-2’s Second-Quarter Benchmarking Analysis

Inside the Lab Industry: Many Labs Expect Five-Year Return on Investment in Web-Based Connectivity Systems Through New Clients, Expanded Business

Bostwick Labs Expands Mid-Atlantic Footprint with Launch of American International Pathology Laboratories

Lab Index Finishes the Summer Strong; Up 18% Over 13 Weeks, 42% for Full Year 2009

Industry Buzz: Myriad Genetics Expands Salesforce by 50 Reps to Aggressively Target Ob-Gyn Market